Total submissions: 11
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000501659 | SCV000596815 | benign | not specified | 2016-09-23 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000651109 | SCV000772959 | benign | Dyskeratosis congenita, autosomal recessive 5; Pulmonary fibrosis and/or bone marrow failure, Telomere-related, 3 | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001543243 | SCV001761770 | benign | Dyskeratosis congenita, autosomal recessive 5 | 2021-07-10 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001543244 | SCV001761771 | benign | Pulmonary fibrosis and/or bone marrow failure, Telomere-related, 3 | 2021-07-10 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001613324 | SCV001840296 | benign | not provided | 2020-01-06 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002413378 | SCV002716320 | likely benign | Inborn genetic diseases | 2022-03-12 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV001613324 | SCV004150983 | likely benign | not provided | 2023-01-01 | criteria provided, single submitter | clinical testing | RTEL1: BP4, BP7, BS2 |
Genome Diagnostics Laboratory, |
RCV001613324 | SCV001926338 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001613324 | SCV001966271 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Laboratory of Diagnostic Genome Analysis, |
RCV000501659 | SCV002035664 | benign | not specified | no assertion criteria provided | clinical testing | ||
Natera, |
RCV001829429 | SCV002095434 | likely benign | Dyskeratosis congenita | 2019-12-19 | no assertion criteria provided | clinical testing |